Goldman Sachs Maintains Neutral on Gentex, Raises Price Target to $35
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Mark Delaney has maintained a Neutral rating on Gentex (NASDAQ:GNTX) and increased the price target from $31 to $35.
January 29, 2024 | 3:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Goldman Sachs has maintained a Neutral rating on Gentex but raised the price target from $31 to $35, indicating a positive outlook on the stock's value.
The increase in price target by a reputable analyst like Goldman Sachs suggests a positive reassessment of Gentex's value, which could lead to increased investor confidence and a potential short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100